Management of Women with Polycystic Ovary Syndrome During Pregnancy

Amy M. Valent, Linda A. Barbour

Research output: Contribution to journalReview articlepeer-review

Abstract

Polycystic ovary syndrome (PCOS) is the most common endocrinopathy among reproductive age women and is associated with subfertility and adverse perinatal outcomes, which may include early pregnancy loss, gestational diabetes mellitus, hypertensive spectrum disorder, preterm birth, fetal growth disorders, and cesarean deliveries. The phenotypic heterogeneity, different diagnostic criteria, and PCOS-related conditions that women enter pregnancy with have limited evidenced-based studies and guidelines to reduce pregnancy complications among this high-risk population. This review summarizes the available evidence on the approach and management of women with PCOS preconception, prenatal, and postpartum.

Original languageEnglish (US)
Pages (from-to)57-69
Number of pages13
JournalEndocrinology and Metabolism Clinics of North America
Volume50
Issue number1
DOIs
StatePublished - Mar 2021

Keywords

  • Metformin
  • Perinatal management
  • Polycystic ovary syndrome
  • Pregnancy complications

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Fingerprint Dive into the research topics of 'Management of Women with Polycystic Ovary Syndrome During Pregnancy'. Together they form a unique fingerprint.

Cite this